Empagliflozin API
Appearance: White powder
Standard: in-house 99%
Brand: YIHUI
Packing: 1kg;25kg
Supply Ability: 5000kg per month
Shelf Life: Two years
Payment: T/T, LC or DA
Sample: available
Delivery Time: Ready Stock in Local Warehouse,1-3 days
Prompt and Secure Shipment
Origin: China
Shipping: DHL,FedEx,TNT,EMS,By Sea,By Air
Certifications: ISO9001, ISO22000, HACCP, HALAL, KOSHER
Can't sell to individuals
- Fast Delievery
- Quality Assurance
- 24/7 Customer Service
Product Introduction
What is Empagliflozin?
Our Empagliflozin API is a cutting-edge pharmaceutical ingredient designed to enhance the management of type 2 diabetes mellitus. Empagliflozin belongs to the class of sodium-glucose co-transporter-2 (SGLT2) inhibitors, revolutionizing diabetes treatment by promoting urinary glucose excretion. Our product is manufactured with precision to ensure purity and efficacy.
Empagliflozin API comes in crystalline form, presenting as a white to light yellowish powder. It exhibits excellent stability and solubility, making it a versatile choice for pharmaceutical formulations. The molecular formula and weight are critical specifications, ensuring consistency and reliability in every batch.
Basic Information
Product Name: Empagliflozin
CAS: 864070-44-0
MF:C23H27ClO7
MW:450.91
EINECS:620-176-8
MDL No.:MFCD22566222
Purity: 99%
Package:1kg;5kg;25kg
Used: Pharma grade & Lab research
Stability: Stable
Structural formula:
Specifications and Parameters
Items | Standards | Results |
Identification | HPLC | Conformed |
Appearance | White to off-White Powder | Conformed |
Melt Point | 150~155℃ | 151.5~153℃ |
Loss on dry | ≤0.5% | 0.2% |
Residue on ignition | ≤0.5% | 0.20% |
Heavy metals | ≤10ppm | 7ppm |
Water content | ≤0.3% | 0.3% |
Optical rotation | +15~+21 | +19 |
Solubility in water | 8-12mg/100ml | 10mg/ 100ml |
Solubility: | soluble in methanol and DCM | Conformed |
Total impurities | ≤0.5% | 0.2% |
Individual impurity (max) | ≤0.1% | 0.07% |
Isomer | ≤0.15% | 0.05% |
Purity (HPLC) | ≥99.5% | 99.8% |
Conclusion: The product confirms to the Enterprise Standard |
Chemical Composition
Component | Percentage Composition |
---|---|
Empagliflozin | 99.5% |
Other Excipients | 0.5% (Fillers, Binders, etc.) |
Effects and Functions
CAS 864070-44-0 plays a crucial role in managing type 2 diabetes mellitus by inhibiting SGLT2, a key player in renal glucose reabsorption. By enhancing urinary glucose excretion, it lowers blood glucose levels, contributing to improved glycemic control. Furthermore, our item has demonstrated cardiovascular advantages, diminishing the risk of major adverse cardiac events in patients with laid out cardiovascular sickness.
It is perceived for its efficacy, safety profile, and positive effect on patient outcomes. Its mechanism of activity makes it a significant part in diabetes therapy regimens, tending to the neglected necessities of people living with this constant condition.
Synthesis Process
The synthesis of the product involves a series of meticulously controlled chemical reactions. Beginning with high-quality raw materials, our cutting edge fabricating process guarantees the purity and consistency of the end result.The synthesis adheres to industry best practices, guaranteeing a pharmaceutical-grade API that meets international standards.
Quality Standards
At Yihui, quality is non-negotiable. Our product undergoes rigorous testing at every stage of production. We adhere to international quality standards, obtaining certifications such as ISO, Kosher, Halal, and GMP. These certifications underscore our commitment to delivering a product that not only meets but exceeds global quality benchmarks.
Application Fields in Various Industries
Empagliflozin API is primarily used in the pharmaceutical industry, where it is a key ingredient in the formulation of medications for diabetes management. As an SGLT2 inhibitor, Empagliflozin helps lower blood sugar levels by promoting the excretion of glucose through urine.
In addition to its pharmaceutical applications, the product also plays a role in research institutions and academic settings. Researchers studying diabetes and related metabolic disorders may utilize the product to investigate its mechanisms of action, explore potential therapeutic uses, and contribute to advancements in diabetes research.
Furthermore, the versatility of the product allows for potential applications beyond the pharmaceutical and research sectors. As new discoveries are made and further research is conducted, its adaptability and relevance across diverse industries may continue to expand. This showcases the potential for the product to have a broader impact on various fields and industries in the future.
OEM Services
Yihui proudly offers OEM services, allowing our partners to leverage our expertise in manufacturing high-quality pharmaceutical ingredients. With a focus on customization, we collaborate closely with clients to meet specific requirements, ensuring the seamless integration of our product into their formulations.
Contact Us
Yihui stands as a beacon of excellence in the production of Empagliflozin API. Committed to quality and meeting the unique needs of our clients, we adhere to strict international standards. Our ISO, Kosher, Halal, and GMP certifications validate our dedication to delivering a product that sets the standard in the pharmaceutical industry. To procure our product or inquire about our OEM services, please contact us immediately at sales@yihuipharm.com. Partner with Yihui for pharmaceutical ingredients you can trust.
Send Message
If you have any enquiry about quotation or cooperation, please feel free to email us at E-mailor use the following enquiry form. Our sales representative will contact you within 24 hours.Thank you for your interest in our products.